RxDoctor Payments Data

Chelsea Luther, MD

Dermatology · Canton, MINPI 1649629510

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.1% of the total across 278 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,289, 2.6 times the $487 reported in 2019.

$6,151in general payments, 2019–2025

Across 278 payments — averaging $22.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • Novartis$654
  • Regeneron Healthcare Solutions, Inc.$646
  • Sanofi$508
  • Sun Pharmaceutical Industries Inc.$427
  • Lilly USA, LLC$422
  • plus $2K from 25 others
$69,173in research payments, 2019–2025

Across 21 payments — averaging $3293.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$69K

What the payments were for

  • Food & beverage$5,66892%
  • Education$4838%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,151 in reported general payments places this provider in the 70th percentile of 404 dermatology providers in Michigan.

See all dermatology providers in Michigan

Medicare billing

Part B allowed, 2024
$94,838
Medicare patients
307
Services billed
2,055

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tacrolimus29$2,344
Fluorouracil31$1,795
Clobetasol Propionate52$1,657
Ketoconazole65$1,190
Fluocinonide29$1,045
Tretinoin21$880
Metronidazole29$846
Hydroxychloroquine Sulfate14$805
Ciclopirox28$753
Hydrocortisone66$527
Triamcinolone Acetonide44$239
Finasteride15$177
Minoxidil14$174
Doxycycline Hyclate18$158

Paid to pharmacies, not to this prescriber.

Other dermatology in Canton

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →